financetom
Business
financetom
/
Business
/
Market Chatter: JPMorgan Plans to Allow Institutional Clients to Use Bitcoin, Ether Holdings as Loan Collateral
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: JPMorgan Plans to Allow Institutional Clients to Use Bitcoin, Ether Holdings as Loan Collateral
Oct 24, 2025 4:03 AM

06:36 AM EDT, 10/24/2025 (MT Newswires) -- JPMorgan Chase ( JPM ) intends to allow institutional clients to use their bitcoin (BTC-USD) and ether (ETH-USD) holdings as collateral for loans by the end of 2025, Bloomberg News reported Friday, citing people familiar with the matter.

The program will be offered globally. It will depend on a third-party custodian for the safeguarding of the pledged tokens, the unnamed sources told the news outlet.

JPMorgan ( JPM ) didn't immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Canadian National Railway's Q1 Adjusted EPS, Revenue Decline
Canadian National Railway's Q1 Adjusted EPS, Revenue Decline
Apr 29, 2026
07:50 AM EDT, 04/29/2026 (MT Newswires) -- Canadian National Railway ( CNI ) reported Q1 adjusted earnings Wednesday of 1.80 Canadian dollars ($0.79) per diluted share, compared with CA$1.85 a year earlier. Analysts surveyed by FactSet expected CA$1.80. Revenue for the quarter ended March 31 was CA$4.38 billion, compared with CA$4.40 billion a year earlier. Analysts surveyed by FactSet expected...
Italian drugmaker Chiesi to buy KalVista for $1.9 billion
Italian drugmaker Chiesi to buy KalVista for $1.9 billion
Apr 29, 2026
April 29 (Reuters) - Italy's Chiesi has agreed to buy KalVista Pharmaceuticals ( KALV ) for about $1.9 billion, the company said on Wednesday, as it looks to grow its rare disease drug portfolio. ...
AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline
AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline
Apr 29, 2026
April 29 (Reuters) - AbbVie ( ABBV ) on Wednesday reported better-than-expected quarterly revenue and profit, fueled by demand for newer immunology drugs Skyrizi and Rinvoq, as the drugmaker continues to navigate its transition away from its once-blockbuster drug, Humira. The company has been leaning heavily on Skyrizi and Rinvoq to fill the void left by Humira, which lost U.S....
AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline
AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline
Apr 29, 2026
April 29 (Reuters) - AbbVie ( ABBV ) on Wednesday reported better-than-expected quarterly revenue and profit, fueled by demand for newer immunology drugs Skyrizi and Rinvoq, as the drugmaker continues to navigate its transition away from its once-blockbuster drug, Humira. The company has been leaning heavily on Skyrizi and Rinvoq to fill the void left by Humira, which lost U.S....
Copyright 2023-2026 - www.financetom.com All Rights Reserved